Therapeutic Monitoring of Infliximab and Adalimumab

Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Infliximab;   Drug: Adalimumab Sponsor:   IRCCS Burlo Garofolo Recruiting

Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials